These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 25672245)

  • 1. Exploiting light chains for the scalable generation and platform purification of native human bispecific IgG.
    Fischer N; Elson G; Magistrelli G; Dheilly E; Fouque N; Laurendon A; Gueneau F; Ravn U; Depoisier JF; Moine V; Raimondi S; Malinge P; Di Grazia L; Rousseau F; Poitevin Y; Calloud S; Cayatte PA; Alcoz M; Pontini G; Fagète S; Broyer L; Corbier M; Schrag D; Didelot G; Bosson N; Costes N; Cons L; Buatois V; Johnson Z; Ferlin W; Masternak K; Kosco-Vilbois M
    Nat Commun; 2015 Feb; 6():6113. PubMed ID: 25672245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing assembly and production of native bispecific antibodies by codon de-optimization.
    Magistrelli G; Poitevin Y; Schlosser F; Pontini G; Malinge P; Josserand S; Corbier M; Fischer N
    MAbs; 2017; 9(2):231-239. PubMed ID: 28001485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational design of a specific heavy chain/κ light chain interface for expressing fully IgG bispecific antibodies.
    Froning KJ; Leaver-Fay A; Wu X; Phan S; Gao L; Huang F; Pustilnik A; Bacica M; Houlihan K; Chai Q; Fitchett JR; Hendle J; Kuhlman B; Demarest SJ
    Protein Sci; 2017 Oct; 26(10):2021-2038. PubMed ID: 28726352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Chain Pairing Variants of Bispecific IgG Expressed in a Single Host Cell by High-Resolution Native and Denaturing Mass Spectrometry.
    Schachner L; Han G; Dillon M; Zhou J; McCarty L; Ellerman D; Yin Y; Spiess C; Lill JR; Carter PJ; Sandoval W
    Anal Chem; 2016 Dec; 88(24):12122-12127. PubMed ID: 28193052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "BIClonals": Production of Bispecific Antibodies in IgG Format in Transiently Transfected Mammalian Cells.
    Litvak-Greenfeld D; Vaks L; Dror S; Nahary L; Benhar I
    Methods Mol Biol; 2019; 1904():431-454. PubMed ID: 30539485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of purification processes for fully human bispecific antibodies based upon modification of protein A binding avidity.
    Tustian AD; Endicott C; Adams B; Mattila J; Bak H
    MAbs; 2016; 8(4):828-38. PubMed ID: 26963837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common light chain chickens produce human antibodies of high affinity and broad epitope coverage for the engineering of bispecifics.
    Ching KH; Berg K; Reynolds K; Pedersen D; Macias A; Abdiche YN; Harriman WD; Leighton PA
    MAbs; 2021; 13(1):1862451. PubMed ID: 33491549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generating bispecific human IgG1 and IgG2 antibodies from any antibody pair.
    Strop P; Ho WH; Boustany LM; Abdiche YN; Lindquist KC; Farias SE; Rickert M; Appah CT; Pascua E; Radcliffe T; Sutton J; Chaparro-Riggers J; Chen W; Casas MG; Chin SM; Wong OK; Liu SH; Vergara G; Shelton D; Rajpal A; Pons J
    J Mol Biol; 2012 Jul; 420(3):204-19. PubMed ID: 22543237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of bispecific F(ab')2 from murine trinoma OC/TR with specificity for CD3 and ovarian cancer.
    Warnaar SO; De Paus V; Lardenoije R; Machielse BN; De Graaf J; Bregonje M; Van Haarlem H
    Hybridoma; 1994 Dec; 13(6):519-26. PubMed ID: 7737675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering bispecific antibodies with defined chain pairing.
    Krah S; Sellmann C; Rhiel L; Schröter C; Dickgiesser S; Beck J; Zielonka S; Toleikis L; Hock B; Kolmar H; Becker S
    N Biotechnol; 2017 Oct; 39(Pt B):167-173. PubMed ID: 28137467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new approach for generating bispecific antibodies based on a common light chain format and the stable architecture of human immunoglobulin G
    De Nardis C; Hendriks LJA; Poirier E; Arvinte T; Gros P; Bakker ABH; de Kruif J
    J Biol Chem; 2017 Sep; 292(35):14706-14717. PubMed ID: 28655766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Productive common light chain libraries yield diverse panels of high affinity bispecific antibodies.
    Van Blarcom T; Lindquist K; Melton Z; Cheung WL; Wagstrom C; McDonough D; Valle Oseguera C; Ding S; Rossi A; Potluri S; Sundar P; Pitts S; Sirota M; Galindo Casas M; Yan Y; Jones J; Roe-Zurz Z; Srivatsa Srinivasan S; Zhai W; Pons J; Rajpal A; Chaparro-Riggers J
    MAbs; 2018; 10(2):256-268. PubMed ID: 29227213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of common light chain IgG-like bispecific antibodies using highly linear pH gradients.
    Sharkey B; Pudi S; Wallace Moyer I; Zhong L; Prinz B; Baruah H; Lynaugh H; Kumar S; Wittrup KD; Nett JH
    MAbs; 2017; 9(2):257-268. PubMed ID: 27937066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin-binding protein-based affinity chromatography in bispecific antibody purification: Functions beyond product capture.
    Li Y
    Protein Expr Purif; 2021 Dec; 188():105976. PubMed ID: 34537355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational selection of building blocks for the assembly of bispecific antibodies.
    Gong D; Riley TP; Bzymek KP; Correia AR; Li D; Spahr C; Robinson JH; Case RB; Wang Z; Garces F
    MAbs; 2021; 13(1):1870058. PubMed ID: 33397191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG-like bispecific antibody platforms with built-in purification-facilitating elements.
    Li Y
    Protein Expr Purif; 2021 Dec; 188():105955. PubMed ID: 34416361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LUZ-Y, a novel platform for the mammalian cell production of full-length IgG-bispecific antibodies.
    Wranik BJ; Christensen EL; Schaefer G; Jackman JK; Vendel AC; Eaton D
    J Biol Chem; 2012 Dec; 287(52):43331-9. PubMed ID: 23118228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EFab domain substitution as a solution to the light-chain pairing problem of bispecific antibodies.
    Cooke HA; Arndt J; Quan C; Shapiro RI; Wen D; Foley S; Vecchi MM; Preyer M
    MAbs; 2018; 10(8):1248-1259. PubMed ID: 30215570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guiding bispecific monovalent antibody formation through proteolysis of IgG1 single-chain.
    Dimasi N; Fleming R; Sachsenmeier KF; Bezabeh B; Hay C; Wu J; Sult E; Rajan S; Zhuang L; Cariuk P; Buchanan A; Bowen MA; Wu H; Gao C
    MAbs; 2017 Apr; 9(3):438-454. PubMed ID: 28055299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precise quantification of mixtures of bispecific IgG produced in single host cells by liquid chromatography-Orbitrap high-resolution mass spectrometry.
    Yin Y; Han G; Zhou J; Dillon M; McCarty L; Gavino L; Ellerman D; Spiess C; Sandoval W; Carter PJ
    MAbs; 2016; 8(8):1467-1476. PubMed ID: 27610742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.